{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:22:44Z","timestamp":1775640164421,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10072-024-07860-7","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T05:04:20Z","timestamp":1730783060000},"page":"1323-1327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Human herpesvirus 6 (HHV-6) encephalitis secondary to chimeric antigen receptor (CAR)-T cell therapy"],"prefix":"10.1007","volume":"46","author":[{"given":"Fahang","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningxiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-561X","authenticated-orcid":false,"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"issue":"1","key":"7860_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1128\/CMR.18.1.217-245.2005","volume":"18","author":"ADDINENREFLIST De Bolle","year":"2005","unstructured":"De Bolle, Naesens LL, De Clercq E (2005) Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18(1):217\u2013245","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"7860_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmi.2015.12.022","volume":"22","author":"DA Clark","year":"2016","unstructured":"Clark DA (2016) Clinical and laboratory features of human herpesvirus 6 chromosomal integration. Clin Microbiol Infect 22(4):333\u2013339","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"7860_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/QCO.0000000000001020","volume":"37","author":"E Kampouri","year":"2024","unstructured":"Kampouri E et al (2024) Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications. Curr Opin Infect Dis 37(4):245\u2013253","journal-title":"Curr Opin Infect Dis"},{"key":"7860_CR4","doi-asserted-by":"crossref","unstructured":"Wang H et al (2024) Clinical and histopathologic characteristics of acute severe Hepatitis Associated with Human Herpesvirus 6 infection. Am J Surg Pathol 48(9): 1117-1130","DOI":"10.1097\/PAS.0000000000002266"},{"key":"7860_CR5","doi-asserted-by":"crossref","unstructured":"Toomey D et al (2023) Viral encephalitis after hematopoietic cell transplantation: a systematic review. Transpl Cell Ther, 29(10): 636.e1-636.e9","DOI":"10.1016\/j.jtct.2023.06.022"},{"key":"7860_CR6","doi-asserted-by":"crossref","unstructured":"Jacobson CA et al (2024) Real-World Outcomes with Chimeric Antigen Receptor T Cell Therapies in Large B Cell Lymphoma: A Systematic Review and Meta-Analysis. Transplant Cell Ther, 30(1): p. 77.e1-77.e15","DOI":"10.1016\/j.jtct.2023.10.017"},{"key":"7860_CR7","doi-asserted-by":"publisher","first-page":"204062072412375","DOI":"10.1177\/20406207241237594","volume":"15","author":"S Yuan","year":"2024","unstructured":"Yuan S, Chen Y, Liu H (2024) Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma. Ther Adv Hematol 15:20406207241237594","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"7860_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMcps2114818","volume":"386","author":"AM Spanjaart","year":"2022","unstructured":"Spanjaart AM et al (2022) Confused about confusion. N Engl J Med 386(1):80\u201387","journal-title":"N Engl J Med"},{"key":"7860_CR9","doi-asserted-by":"crossref","unstructured":"Mardente S et al (2023) HHV-6A infection of papillary thyroid Cancer cells induces several effects related to Cancer Progression. Viruses 15(10): 2122","DOI":"10.3390\/v15102122"},{"issue":"1","key":"7860_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/brain\/awad374","volume":"147","author":"V Grut","year":"2024","unstructured":"Grut V et al (2024) Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis. Brain 147(1):177\u2013185","journal-title":"Brain"},{"key":"7860_CR11","doi-asserted-by":"publisher","first-page":"1030440","DOI":"10.3389\/fmicb.2022.1030440","volume":"13","author":"A Badrinath","year":"2022","unstructured":"Badrinath A, Bhatta S, Kloc A (2022) Persistent viral infections and their role in heart disease. Front Microbiol 13:1030440","journal-title":"Front Microbiol"},{"issue":"1","key":"7860_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1086\/498531","volume":"193","author":"M Ogata","year":"2006","unstructured":"Ogata M et al (2006) Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 193(1):68\u201379","journal-title":"J Infect Dis"},{"issue":"1","key":"7860_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrclinonc.2015.187","volume":"13","author":"CL Batlevi","year":"2016","unstructured":"Batlevi CL et al (2016) Novel immunotherapies in lymphoid malignancies. Nat Rev Clin Oncol 13(1):25\u201340","journal-title":"Nat Rev Clin Oncol"},{"issue":"7987","key":"7860_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-023-06704-2","volume":"623","author":"CA Lareau","year":"2023","unstructured":"Lareau CA et al (2023) Latent human herpesvirus 6 is reactivated in CAR T cells. Nature 623(7987):608\u2013615","journal-title":"Nature"},{"key":"7860_CR15","doi-asserted-by":"crossref","unstructured":"Yamshon S et al (2024) Safety and toxicity profiles of CAR T cell therapy in Non-hodgkin Lymphoma: a systematic review and Meta-analysis. Clin Lymphoma Myeloma Leuk, 24(6): e235-e256.e2.","DOI":"10.1016\/j.clml.2024.02.007"},{"key":"7860_CR16","doi-asserted-by":"crossref","unstructured":"Pinto SN, Krenciute G (2024) The mechanisms of altered blood-brain barrier permeability in CD19 CAR T-Cell recipients. Int J Mol Sci, 25(1): 644","DOI":"10.3390\/ijms25010644"},{"key":"7860_CR17","doi-asserted-by":"publisher","first-page":"879608","DOI":"10.3389\/fimmu.2022.879608","volume":"13","author":"RC Sterner","year":"2022","unstructured":"Sterner RC, Sterner RM (2022) Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy. Front Immunol 13:879608","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"7860_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hon.2595","volume":"37","author":"SS Neelapu","year":"2019","unstructured":"Neelapu SS (2019) Managing the toxicities of CAR T-cell therapy. Hematol Oncol 37(Suppl 1):48\u201352","journal-title":"Hematol Oncol"},{"key":"7860_CR19","doi-asserted-by":"crossref","unstructured":"Lakomy T et al (2023) Early Use of corticosteroids following CAR T-Cell therapy correlates with reduced risk of high-Grade CRS without negative impact on neurotoxicity or treatment outcome. Biomolecules, 13(2): 382","DOI":"10.3390\/biom13020382"},{"key":"7860_CR20","doi-asserted-by":"crossref","unstructured":"Kampouri E, Handley G, Hill JA (2024) Human herpes Virus-6 (HHV-6) reactivation after hematopoietic cell transplant and Chimeric Antigen Receptor (CAR)- T cell therapy: a shifting Landscape. Viruses, 16(4): 498","DOI":"10.3390\/v16040498"},{"key":"7860_CR21","doi-asserted-by":"crossref","unstructured":"Kampouri E et al (2024) Human Herpesvirus-6 Reactivation and Disease Are Infrequent in Chimeric Antigen Receptor T-cell Therapy Recipients. Blood 144(5): 490-495","DOI":"10.1182\/blood.2024024145"},{"key":"7860_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.amsu.2020.10.022","volume":"60","author":"A Yassin","year":"2020","unstructured":"Yassin A et al (2020) Clinical, radiological, and electroencephalographic features of HHV-6 encephalitis following hematopoietic stem cell transplantation. Ann Med Surg (Lond) 60:81\u201386","journal-title":"Ann Med Surg (Lond)"},{"issue":"12","key":"7860_CR23","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1097\/00007890-200006270-00002","volume":"69","author":"N Singh","year":"2000","unstructured":"Singh N, Paterson DL (2000) Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 69(12):2474\u20132479","journal-title":"Transplantation"},{"issue":"16","key":"7860_CR24","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1212\/WNL.0b013e31828cf8a2","volume":"80","author":"MJ Bhanushali","year":"2013","unstructured":"Bhanushali MJ et al (2013) Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology 80(16):1494\u20131500","journal-title":"Neurology"},{"issue":"4","key":"7860_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW et al (2019) ASTCT Consensus Grading for Cytokine Release Syndrome and neurologic toxicity Associated with Immune Effector cells. Biol Blood Marrow Transpl 25(4):625\u2013638","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"7860_CR26","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/brain\/awz053","volume":"142","author":"DB Rubin","year":"2019","unstructured":"Rubin DB et al (2019) Neurological toxicities associated with chimeric antigen receptor T-cell therapy. Brain 142(5):1334\u20131348","journal-title":"Brain"},{"issue":"2","key":"7860_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/neuonc\/noab174","volume":"24","author":"I Beuchat","year":"2022","unstructured":"Beuchat I et al (2022) EEG findings in CAR T-cell-associated neurotoxicity: clinical and radiological correlations. Neuro Oncol 24(2):313\u2013325","journal-title":"Neuro Oncol"},{"key":"7860_CR28","doi-asserted-by":"crossref","unstructured":"Li A et al (2020) Direct economic burden of patients with autoimmune encephalitis in western China. Neurol Neuroimmunol Neuroinflamm, 7(6): e891","DOI":"10.1212\/NXI.0000000000000891"},{"issue":"10","key":"7860_CR29","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1080\/10428194.2022.2074990","volume":"63","author":"AH Lapidus","year":"2022","unstructured":"Lapidus AH et al (2022) Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy. Leuk Lymphoma 63(10):2364\u20132374","journal-title":"Leuk Lymphoma"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07860-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:58:47Z","timestamp":1739559527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07860-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7860"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07860-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The participant had given consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Authors declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}